Fistula Needles Sales

Fistula Needles Sales Market Outlook

The global fistula needles market is poised for significant growth, with a projected market size reaching approximately USD 1.5 billion by 2035, expanding at a noteworthy Compound Annual Growth Rate (CAGR) of around 7.2% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of chronic kidney diseases and the rising number of patients requiring hemodialysis treatments. Additionally, advancements in medical technology and the development of innovative needle designs that enhance patient comfort and ease of use are further driving the market demand. As healthcare providers increasingly focus on improving patient outcomes, the demand for specialized devices like fistula needles is expected to rise. Moreover, the growing awareness of blood transfusion safety and protocols related to dialysis procedures is contributing to the enhanced usage of these needles in various medical settings.

Growth Factor of the Market

One of the key growth factors for the fistula needles market is the rising incidence of end-stage renal disease (ESRD), which requires frequent hemodialysis treatments. As the global population ages and lifestyle-related diseases become more prevalent, the demand for reliable and efficient dialysis solutions is increasing. Furthermore, the healthcare sector is witnessing a surge in investments aimed at improving dialysis facilities, which directly correlates with the demand for specialized instruments, including fistula needles. The increasing focus on patient-centered care and innovations in needle design that minimize pain and complications during dialysis procedures are also pivotal in enhancing market growth. Moreover, regulatory approvals for advanced products and improvements in healthcare infrastructure, especially in developing regions, are likely to create new opportunities for market players. The shift towards outpatient dialysis treatments and home-based care options will further bolster the need for effective fistula needles, making this market a focal point for both manufacturers and healthcare providers.

Key Highlights of the Market

• Projected CAGR of 7.2% from 2025 to 2035, indicating strong market growth.
• Increasing prevalence of chronic kidney disease driving demand for hemodialysis.
• Rising investments in healthcare infrastructure, particularly in developing regions.
• Innovative needle designs focusing on patient comfort and safety enhancing market appeal.
• Regulatory advancements supporting the introduction of new fistula needle products.

By Product Type

Buttonhole Needles:

Buttonhole needles are specially designed for patients undergoing regular hemodialysis treatments, allowing for the creation of a stable fistula site. This type of needle features a more blunt end, which is less traumatic to the tissue, making repeated insertions less painful and reducing the risk of complications such as infiltration or phlebitis. The buttonhole technique promotes the use of the same puncture site, leading to greater patient comfort and improved healing outcomes. As a result, the adoption of buttonhole needles is on the rise, particularly among patients who have long-term vascular access for dialysis. Their growing popularity reflects a significant shift towards minimizing pain and enhancing the overall dialysis experience for patients.

Rope Ladder Needles:

Rope ladder needles are utilized primarily in the fistula access method for hemodialysis, where two access points are created to facilitate better blood flow. This needle type is preferred for its ability to minimize trauma to the existing vascular access site, thus reducing complications associated with needle insertion. The design allows healthcare providers to effectively use the surrounding tissues for access, creating less stress on the fistula that can lead to vascular complications. Given the increasing focus on patient safety and the need for effective blood flow during dialysis, the demand for rope ladder needles is expected to witness significant growth in the coming years.

Winged Steel Needles:

Winged steel needles, often referred to as "butterfly needles," are characterized by their unique design that provides better control during insertion. They are particularly useful in various medical applications, including blood draws and infusions, due to their stability and ease of use. In the context of hemodialysis, these needles allow for secure and precise access to the bloodstream, minimizing discomfort for patients. The flexibility in their application across different clinical settings, along with a growing trend towards more versatile medical devices, is likely to contribute to the increasing adoption of winged steel needles in the fistula needles market.

Non-Coring Needles:

Non-coring needles are designed to create a smaller and cleaner access point in the fistula, thereby reducing the risk of tissue damage and complications. They are particularly beneficial for repeated access points and are known for their ability to minimize the risk of blood leaks during dialysis procedures. As healthcare providers focus on optimizing patient outcomes and reducing the incidence of complications associated with needle use, the demand for non-coring needles is expected to rise. Their effectiveness in maintaining a viable access point while ensuring patient safety positions them as a significant player within the fistula needles market.

Others:

This category encompasses various other specialized needle types and designs that cater to specific medical needs and patient populations. Innovations in materials and designs, such as retractable needles and those that incorporate features for enhanced safety, are contributing to this segment's growth. As the healthcare sector continues to evolve towards safer and more effective medical devices, this 'Others' category is likely to expand, reflecting broader trends in patient care and technology integration in medical devices.

By Application

Hemodialysis:

Hemodialysis is the primary application for fistula needles, with a considerable portion of the market dedicated to devices used in this setting. These needles are essential for accessing the bloodstream during the dialysis process, facilitating the removal of toxins and excess fluids from patients with kidney dysfunction. Given the rising prevalence of chronic kidney disease globally, the need for efficient hemodialysis treatment continues to surge. Moreover, advancements in dialysis technology and techniques are also expected to enhance needle product offerings, ensuring patient comfort and improving treatment efficacy. The increasing number of dialysis centers and outpatient facilities is further propelling the demand for specialized hemodialysis needles.

Blood Transfusion:

Fistula needles are also utilized in blood transfusion applications, where their design ensures stable and secure access to the vascular system. The ability to perform transfusions with minimal trauma to the vascular tissues makes these needles a preferred choice in various medical settings. As blood transfusions become a routine part of patient care, particularly in surgical and oncology settings, the demand for high-quality needles that can facilitate quick and safe access to veins is expected to grow. Additionally, ongoing improvements in transfusion protocols and safety measures will likely enhance the market for fistula needles in this application.

Plasma Exchange:

Plasma exchange is a therapeutic procedure that requires secure and efficient access to the bloodstream, making fistula needles crucial in this process. The use of these needles helps healthcare professionals to perform the procedure with greater ease and accuracy, minimizing patient discomfort and improving overall outcomes. As awareness of plasma exchange benefits grows, particularly in treating autoimmune diseases and certain neurological disorders, the demand for effective and reliable needle options is anticipated to increase. The market for plasma exchange applications is thus expected to experience growth, driven by the rising prevalence of conditions requiring such treatment.

Drug Administration:

In addition to their use in dialysis, fistula needles are increasingly employed for drug administration, particularly in patients requiring ongoing therapy for chronic conditions. The ability to provide secure vascular access facilitates timely administration of medications, reducing the need for multiple venipunctures. As healthcare continues to move towards more integrated and patient-centered approaches, the demand for reliable and flexible needle options for drug delivery is likely to rise. This trend is further supported by the increasing complexity of treatment protocols that often necessitate multiple routes of medication administration, reinforcing the need for specialized needles.

Others:

This category includes various applications of fistula needles that may not fall under the primary classifications but are still significant within specific healthcare contexts. This might involve niche applications in research settings or unique treatment protocols tailored to specific patient populations. The diversification of applications is indicative of the growing versatility of fistula needle designs and their increasing integration into different therapeutic regimes. As the healthcare landscape evolves, so too will the opportunities for various applications of these essential medical devices.

By Distribution Channel

Hospitals:

Hospitals remain one of the primary distribution channels for fistula needles, given their extensive use in a range of medical procedures, particularly in dialysis and transfusion services. The centralized nature of hospital services allows for streamlined procurement processes, thereby ensuring the availability of high-quality medical supplies, including fistula needles. With hospitals generally being the first point of contact for patients requiring specialized care for chronic conditions, the demand for reliable and effective needles is significant. Moreover, as hospitals increasingly adopt technologically advanced medical devices, the market for fistula needles is expected to experience considerable growth through this channel.

Specialty Clinics:

Specialty clinics, particularly those focused on nephrology and chronic disease management, play a crucial role in the distribution of fistula needles. These clinics cater specifically to patients requiring ongoing treatment for conditions such as chronic kidney disease, thus creating a consistent demand for dialysis supplies. As more patients seek care within specialty environments that emphasize personalized treatment plans, the relevance of fistula needles within these clinics becomes even more pronounced. The tailored services offered by specialty clinics, combined with increasing patient awareness and preference for targeted care, are likely to drive growth in the fistula needle market through this distribution channel.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) provide a critical distribution channel for fistula needles, particularly for outpatient procedures that require vascular access. The rising trend towards outpatient care, which allows patients to receive treatment and return home on the same day, has spurred demand for devices that can offer quick and efficient access to the bloodstream. Fistula needles are essential in these settings, as they facilitate the timely completion of various procedures while ensuring patient safety and comfort. As ASCs continue to grow in prevalence due to their cost-effectiveness and convenience, they will significantly contribute to the market expansion for fistula needles.

Dialysis Centers:

Dialysis centers are dedicated facilities that specialize in providing renal replacement therapy to patients with kidney failure, making them a key distribution channel for fistula needles. These centers require a steady supply of specialized medical supplies, including needles, to ensure effective treatment delivery. The increasing number of dialysis centers being established globally in response to the rising prevalence of chronic kidney disease is expected to significantly boost the demand for fistula needles. Additionally, as these centers continue to evolve and incorporate new technologies aimed at enhancing treatment efficiency, the need for innovative needle designs that complement advanced dialysis systems will also rise.

Others:

This category includes various alternative distribution channels that may deliver fistula needles to healthcare providers or directly to consumers. This could encompass online medical supply platforms, local pharmacies, and other specialized suppliers that cater to niche markets. The growth of e-commerce in healthcare supplies has enabled patients and providers to access a broader range of products conveniently. Furthermore, as the healthcare industry continues to innovate and adapt to changing consumer preferences, the significance of these alternative channels is likely to grow, expanding the market reach of fistula needles.

By Material Type

Stainless Steel:

Stainless steel is the most commonly used material for manufacturing fistula needles due to its strength, durability, and resistance to corrosion. This material ensures that the needles maintain their integrity and performance even under the demands of repeated use in hemodialysis and other procedures. Additionally, stainless steel needles are easy to sterilize, making them a safe option for medical applications. The longstanding reliability of stainless steel as a material choice contributes to its dominance in the fistula needles market, as healthcare providers continue to prioritize quality and safety in their medical supplies.

Teflon-coated:

Teflon-coated needles are designed to enhance patient comfort by reducing friction during insertion and while moving through the tissue. The coating allows for smoother needle movement, which is particularly beneficial during repeated access scenarios in hemodialysis. This feature minimizes trauma to the vascular access site, resulting in less pain and discomfort for patients. As healthcare providers increasingly focus on improving the patient experience during treatments, Teflon-coated fistula needles are gaining popularity and may experience growth in demand as a preferred option in the market.

Silicone-coated:

Silicone-coated needles offer similar benefits to Teflon-coated options, providing a smooth surface that reduces the risk of complications during puncture and withdrawal. The silicone coating enhances the glide of the needle, allowing for easy insertion and improved patient comfort. This material type is particularly useful in applications requiring repeated access, as it minimizes tissue trauma and promotes better healing at the puncture site. Given the rising emphasis on minimizing pain and optimizing patient care, the market for silicone-coated fistula needles is expected to expand as more healthcare facilities adopt these innovative solutions.

Polyurethane:

Polyurethane needles are less common but are recognized for their flexibility and strength. This material is particularly advantageous in scenarios requiring a balance between durability and adaptability, which can be critical for certain medical applications. Furthermore, polyurethane has excellent biocompatibility, making it suitable for sensitive patients who may have adverse reactions to other materials. As the healthcare industry seeks to develop more versatile and patient-friendly needle options, the demand for polyurethane needles is anticipated to grow, reflecting changing preferences and requirements in patient care.

Others:

The 'Others' category consists of emerging materials and innovative designs that offer unique benefits tailored to specific medical needs. This may include biodegradable materials or advanced alloys that enhance the performance and safety of the needles. As research and development in medical technology continue, new material options are likely to emerge, contributing to the overall growth of the fistula needles market. The increasing focus on sustainability and reducing environmental impact may also drive interest in alternative materials, thus broadening the scope of the 'Others' segment.

By Region

The regional analysis of the fistula needles market reveals a dynamic landscape influenced by varying healthcare demands and infrastructural developments. North America holds a significant share of the market, driven primarily by the high prevalence of chronic kidney diseases and the established healthcare infrastructure that supports advanced medical technologies. The region is projected to witness a CAGR of around 6.5% over the forecast period, backed by rising investments in healthcare and an increasing number of dialysis centers. Europe follows closely with a robust market presence, where the growing elderly population and advancements in medical technology contribute to the demand for specialized medical devices, including fistula needles.

In the Asia Pacific region, the fistula needles market is expected to exhibit rapid growth, with a CAGR projected at approximately 8% during the forecast period. This growth is attributed to the rising incidence of chronic illnesses, increased healthcare spending, and the expansion of healthcare facilities across countries such as India and China. Latin America and the Middle East & Africa are also emerging markets, driven by ongoing improvements in healthcare infrastructure and growing awareness of advanced treatment options. Collectively, these regional dynamics will shape the overall landscape of the fistula needles market, influencing product development and marketing strategies across different geographies.

Opportunities

Emerging markets represent a significant opportunity for the fistula needles market, particularly in regions where healthcare infrastructure is rapidly developing. Countries in Asia, Africa, and Latin America are investing heavily in healthcare services to address the rising burden of chronic diseases, including kidney-related conditions. This presents a lucrative opportunity for manufacturers to introduce innovative and affordable fistula needle products designed to meet the specific needs of these markets. Additionally, the increasing focus on establishing dialysis centers and enhancing patient access to renal care will further drive demand for these specialized needles. By strategically positioning their products in these growing markets, companies can capitalize on the expanding customer base and contribute to improved patient outcomes on a global scale.

Moreover, advancements in technology continue to enhance the design and functionality of medical devices, providing further opportunities for innovation in the fistula needles market. The integration of smart technologies, such as needle tracking systems and features that enhance ease of use, can distinguish product offerings and improve patient experiences. As healthcare providers look for ways to enhance treatment efficacy and patient comfort, manufacturers who prioritize research and development in innovative needle designs are likely to gain a competitive edge. Additionally, collaborations with healthcare institutions to develop tailored products that align with specific treatment protocols can also unlock new opportunities for growth.

Threats

Despite the numerous opportunities within the fistula needles market, companies face significant threats that could hinder growth. One of the primary challenges is the increasing competition from alternative vascular access devices that may offer similar or improved outcomes. As technology evolves, new products may enter the market, potentially displacing traditional fistula needles. Additionally, stringent regulatory requirements and lengthy approval processes can pose barriers for manufacturers looking to introduce innovative products, slowing down time to market and increasing costs. Companies must remain vigilant and responsive to these competitive pressures while continuing to prioritize quality and patient safety in their product offerings.

Moreover, fluctuating raw material prices and supply chain disruptions can impact production costs and availability, leading to potential market volatility. Economic downturns or unforeseen global events, such as pandemics, can also affect healthcare budgets and spending priorities, causing delays in purchasing decisions for medical supplies. Manufacturers must develop robust risk management strategies and maintain flexible supply chains to mitigate these threats and ensure business continuity in a rapidly changing market environment.

Competitor Outlook

• Fresenius Medical Care AG & Co. KGaA
• Baxter International Inc.
• Medtronic plc
• Terumo Corporation
• Smiths Medical
• BD (Becton, Dickinson and Company)
• AngioDynamics, Inc.
• Dialyze Direct
• Cook Medical
• Nipro Corporation
• 3M Company
• Vygon S.A.
• Fischer Medical Technologies
• APEX Medical Corporation
• Rita Medical Systems, Inc.

The competitive landscape of the fistula needles market is characterized by a mix of established multinational corporations and innovative startups. Companies like Fresenius Medical Care and Baxter International maintain a strong foothold in the market, leveraging their extensive product portfolios and global distribution networks to cater to healthcare providers across various regions. These organizations invest heavily in research and development to enhance their product offerings, ensuring they remain at the forefront of technological advancements in needle design and functionality. Additionally, their strong relationships with healthcare institutions allow them to stay informed on emerging trends and patient needs, further positioning them for success in the evolving market landscape.

Medtronic and Terumo Corporation are also significant players, known for their commitment to improving patient outcomes through innovative medical devices. These companies continuously explore opportunities for collaboration with healthcare professionals to develop products that meet specific clinical challenges. As a result, they are well-equipped to address the increasing demand for specialized needles, such as those designed for hemodialysis and blood transfusion applications. By prioritizing patient-centric designs and enhancing the overall user experience, these companies contribute to the ongoing evolution of the fistula needles market.

Smaller companies and niche players also play an essential role in the competitive landscape, introducing unique products that cater to specialized needs. Organizations such as Dialyze Direct and Cook Medical are focusing on developing innovative solutions that enhance the quality of care for patients requiring dialysis and other critical procedures. Their agility in responding to market changes and willingness to experiment with new materials, designs, and technologies enables them to carve out a niche in this competitive environment. As the market continues to grow, these companies will likely emerge as key contributors to its development, driving innovation and expanding options for healthcare providers and patients alike.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Vygon S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Cook Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Dialyze Direct
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smiths Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Nipro Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 AngioDynamics, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 APEX Medical Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Baxter International Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Rita Medical Systems, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Fischer Medical Technologies
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fresenius Medical Care AG & Co. KGaA
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Fistula Needles Sales Market, By Application
    • 6.1.1 Hemodialysis
    • 6.1.2 Blood Transfusion
    • 6.1.3 Plasma Exchange
    • 6.1.4 Drug Administration
    • 6.1.5 Others
  • 6.2 Fistula Needles Sales Market, By Product Type
    • 6.2.1 Buttonhole Needles
    • 6.2.2 Rope Ladder Needles
    • 6.2.3 Winged Steel Needles
    • 6.2.4 Non-Coring Needles
    • 6.2.5 Others
  • 6.3 Fistula Needles Sales Market, By Material Type
    • 6.3.1 Stainless Steel
    • 6.3.2 Teflon-coated
    • 6.3.3 Silicone-coated
    • 6.3.4 Polyurethane
    • 6.3.5 Others
  • 6.4 Fistula Needles Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Dialysis Centers
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Fistula Needles Sales Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Fistula Needles Sales market is categorized based on

By Product Type

• Buttonhole Needles
• Rope Ladder Needles
• Winged Steel Needles
• Non-Coring Needles
• Others

By Application

• Hemodialysis
• Blood Transfusion
• Plasma Exchange
• Drug Administration
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Dialysis Centers
• Others

By Material Type

• Stainless Steel
• Teflon-coated
• Silicone-coated
• Polyurethane
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Fresenius Medical Care AG & Co. KGaA
• Baxter International Inc.
• Medtronic plc
• Terumo Corporation
• Smiths Medical
• BD (Becton, Dickinson and Company)
• AngioDynamics, Inc.
• Dialyze Direct
• Cook Medical
• Nipro Corporation
• 3M Company
• Vygon S.A.
• Fischer Medical Technologies
• APEX Medical Corporation
• Rita Medical Systems, Inc.